ClinicalTrials.gov
public full text
Public Domain
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
This Phase 2, double-blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant (CORT118335) in obese patients with schizophrenia treated with antipsychotic medications.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices#1047221
- Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients#883004
- Efficacy of Bifeprunox in Patients With Schizophrenia#864637
- Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder#800861
- Evaluating the Pharmacokinetics and Safety of Miricorilant#894418
Record · ID 897825
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive